首页 | 本学科首页   官方微博 | 高级检索  
     

阿尔茨海默病治疗药物多奈哌齐的合成研究进展
引用本文:张宜凡. 阿尔茨海默病治疗药物多奈哌齐的合成研究进展[J]. 中国药业, 2009, 18(15): 1-3
作者姓名:张宜凡
作者单位:上海医药高等专科学校药学系,上海,201318
摘    要:多奈哌齐为1-苄基-4-[(5,6-二甲氧基-1-茚酮)-2-亚甲基]哌啶盐酸盐,是第2代可逆性乙酰胆碱酯酶(AChE)抑制剂,为美国食品与药物监督管理局(FDA)批准用于治疗阿尔茨海默病(AD)的第2个药物。该文介绍了多奈哌齐的合成方法,并比较了各种方法的优缺点,试图寻找一条适合大规模、商业化生产的工艺路线。

关 键 词:多奈哌齐  阿尔茨海默病  合成路线

Research Progress on Synthetic Process of Donepezil for Treating Alzheimer's Disease
Zhang Yifan. Research Progress on Synthetic Process of Donepezil for Treating Alzheimer's Disease[J]. China Pharmaceuticals, 2009, 18(15): 1-3
Authors:Zhang Yifan
Affiliation:Zhang Yifan(Department of Pharmacy, Shanghai Institute of Health Sciences, Shanghai, China 201318)
Abstract:Donepezil named 1-benzyl-4- [(5, 6- dimethoxy- 1-indanon)-2-methylene] piperidine hydrochloride is the second generation reversibility anticholinesterase inhibitor and the second medicament for treating Alzheimer's disease (AD) authorized by FDA. This review summarizes the various synthetic processes of donepezil. By comparison of the merits and demerits of the process for the preparation of donepezil, try to find a route which shows more favorable commercial value in the manufacturing scale.
Keywords:donepezil  Alzheimer' s disease  synthesis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号